These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 7691722

  • 1. Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen.
    Mishra A, Rao KV, Durgapal H, Manivel V, Panda SK.
    Immunology; 1993 Jul; 79(3):362-7. PubMed ID: 7691722
    [Abstract] [Full Text] [Related]

  • 2. Identification of T cell epitopes on hepatitis B surface antigen.
    Vento S.
    Ann Ist Super Sanita; 1991 Jul; 27(1):37-40. PubMed ID: 1720295
    [Abstract] [Full Text] [Related]

  • 3. Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals.
    Bauer T, Weinberger K, Jilg W.
    Hepatology; 2002 Feb; 35(2):455-65. PubMed ID: 11826423
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis.
    Celis E, Kung PC, Chang TW.
    J Immunol; 1984 Mar; 132(3):1511-6. PubMed ID: 6198394
    [Abstract] [Full Text] [Related]

  • 5. Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides.
    Celis E, Ou D, Otvos L.
    J Immunol; 1988 Mar 15; 140(6):1808-15. PubMed ID: 2450132
    [Abstract] [Full Text] [Related]

  • 6. A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg.
    Milich DR, McLachlan A, Moriarty A, Thornton GB.
    J Immunol; 1987 Jun 15; 138(12):4457-65. PubMed ID: 2438344
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity.
    Milich DR, Peterson DL, Leroux-Roels GG, Lerner RA, Chisari FV.
    J Immunol; 1985 Jun 15; 134(6):4203-11. PubMed ID: 2580909
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.
    Livingston BD, Crimi C, Grey H, Ishioka G, Chisari FV, Fikes J, Grey H, Chesnut RW, Sette A.
    J Immunol; 1997 Aug 01; 159(3):1383-92. PubMed ID: 9233635
    [Abstract] [Full Text] [Related]

  • 11. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY, Chang MH, Hsieh RP, Ni YH, Chi WK.
    Hepatology; 1996 Dec 01; 24(6):1355-60. PubMed ID: 8938161
    [Abstract] [Full Text] [Related]

  • 12. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen.
    Milich DR, Jones JE, McLachlan A, Bitter G, Moriarty A, Hughes JL.
    J Immunol; 1990 May 01; 144(9):3544-51. PubMed ID: 1691763
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP, Doan T, Herd KA, Netter HJ, Tindle RW.
    J Virol; 2006 Apr 01; 80(8):3975-84. PubMed ID: 16571814
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site.
    Milich DR, McLachlan A, Thornton GB, Hughes JL.
    Nature; 2006 Apr 01; 329(6139):547-9. PubMed ID: 2443856
    [Abstract] [Full Text] [Related]

  • 16. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.
    Couillin I, Pol S, Mancini M, Driss F, Bréchot C, Tiollais P, Michel ML.
    J Infect Dis; 1999 Jul 01; 180(1):15-26. PubMed ID: 10353856
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.